Literature DB >> 9760578

A two-step model for the induction of organ-specific autoimmunity.

A Limmer1, T Sacher, J Alferink, T Nichterlein, B Arnold, G J Hämmerling.   

Abstract

Peripheral tolerance is considered to be a safeguard against autoimmunity but the mere existence of anergic T cells renders them potentially dangerous. Using transgenic mice that were tolerant to a foreign MHC class I antigen (Kb) exclusively expressed in the liver, we investigated whether reversal of tolerance in vivo would directly result in autoimmunity. Breaking of tolerance was achieved by application of tumour cells expressing both Kb and interleukin 2. Despite the fact that the respective mice were now able to reject Kb-positive grafts, the reversed T cells did not infiltrate and attack the Kb-positive liver. However, when the liver was 'conditioned' through an inflammatory reaction either by irradiation or by infection with Listeria, massive T cell infiltration and liver damage were observed in the reversed mice. The results show that at least two steps are required for autoimmunity: (1) activation of antigen-specific T cells, and (2) conditioning of the target organ. It will be important to determine the factors leading to conditioning but it is likely that adhesion molecules are involved. These experiments are not only of relevance for treatment of autoimmune disease but also for tumour therapy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9760578     DOI: 10.1002/9780470515525.ch12

Source DB:  PubMed          Journal:  Novartis Found Symp        ISSN: 1528-2511


  2 in total

1.  Experimental autoimmune encephalomyelitis in mice expressing the autoantigen MBP 1-10 covalently bound to the MHC class II molecule I-Au.

Authors:  Florian C Kurschus; Thilo Oelert; Birgit Liliensiek; Pascale Buchmann; David C Wraith; Günter J Hämmerling; Bernd Arnold
Journal:  Int Immunol       Date:  2005-12-16       Impact factor: 4.823

Review 2.  Hepatitis mouse models: from acute-to-chronic autoimmune hepatitis.

Authors:  Muhammed Yüksel; Debby Laukens; Femke Heindryckx; Hans Van Vlierberghe; Anja Geerts; F Susan Wong; Li Wen; Isabelle Colle
Journal:  Int J Exp Pathol       Date:  2014-08-12       Impact factor: 1.925

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.